Abstract
In a recent Nature article, Middleton etal. report the National Lung Matrix trial results where patients with previously treated non-small cell lung cancer (NSCLC) are assigned to personalized therapy based on the results of a 28-gene next-generation sequencing panel test.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have